A case of refractory severe pyoderma gangrenosum successfully treated with upadacitinib

Dig Liver Dis. 2024 Jul;56(7):1248. doi: 10.1016/j.dld.2024.03.016. Epub 2024 Apr 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Middle Aged
  • Pyoderma Gangrenosum* / drug therapy

Substances

  • Heterocyclic Compounds, 3-Ring
  • upadacitinib